Top-selling drug Farxiga sees potential to reach more patients
One of AstraZeneca Plc's top-selling drugs Farxiga, a diabetes treatment, is beneficial to a wider pool of patients than previously indicated, a study shows, bolstering the product's blockbuster potential.
Aug 29, 2022
0
5